about
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study
P50
description
researcher
@en
name
Fabrizio Ginevri
@en
type
label
Fabrizio Ginevri
@en
prefLabel
Fabrizio Ginevri
@en
P31
P496
0000-0003-2377-8774